Literature DB >> 23447523

Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient.

Garrett R Roll1, Justin R Parekh, William F Parker, Mark Siegler, Elizabeth A Pomfret, Nancy L Ascher, John Paul Roberts.   

Abstract

Living donor liver transplantation (LDLT), originally used in children with left lateral segment grafts, has been expanded to adults who require larger grafts to support liver function. Most adult LDLT procedures have been performed with right lobe grafts, and this means a significant risk of morbidity for the donors. To minimize the donor risk for adults, there is renewed interest in smaller left lobe grafts. The smaller graft size increases the recipient risk in the form of small-for-size syndrome (SFSS) and essentially transfers the risk from the donor to the recipient. We review the donor and recipient risks of LDLT and pay particular attention to the different types of liver grafts and the use of graft inflow modification to ameliorate the risk of SFSS. Finally, a new metric is proposed for quantifying the recipient benefit in exchange for a specific donor risk.
Copyright © 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23447523     DOI: 10.1002/lt.23608

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  22 in total

Review 1.  Portosystemic Shunts for "Too Small-for-Size Syndrome" After Liver Transplantation: A Systematic Review.

Authors:  Erdem Kinaci; Cuneyt Kayaalp
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

Review 2.  [Living liver donor: indications and technical aspects].

Authors:  S Nadalin; I Capobianco; I Königsrainer; B Harder; A Königsrainer
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

Review 3.  Small-for-size syndrome in living-donor liver transplantation using a left lobe graft.

Authors:  Masahiko Taniguchi; Tsuyoshi Shimamura; Satoru Todo; Hiroyuki Furukawa
Journal:  Surg Today       Date:  2014-06-05       Impact factor: 2.549

4.  Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome.

Authors:  Jay A Graham; Benjamin Samstein; Jean C Emond
Journal:  Curr Transplant Rep       Date:  2014-03

5.  Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.

Authors:  James J Pomposelli; Nathan P Goodrich; Jean C Emond; Abhinav Humar; Talia B Baker; David R Grant; Robert A Fisher; John P Roberts; Kim M Olthoff; Brenda W Gillespie; Robert M Merion
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

Review 6.  [Living related liver transplantation].

Authors:  H-M Tautenhahn; F Rauchfuß; A Ali Deeb; A Bauschke; U Settmacher
Journal:  Chirurg       Date:  2020-11       Impact factor: 0.955

Review 7.  Laparoscopic liver resection for living donation: where do we stand?

Authors:  François Cauchy; Lilian Schwarz; Olivier Scatton; Olivier Soubrane
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

8.  The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute.

Authors:  Naoya Yamada; Yukihiro Sanada; Yuta Hirata; Noriki Okada; Yoshiyuki Ihara; Hideki Sasanuma; Taizen Urahashi; Yasunaru Sakuma; Yoshikazu Yasuda; Koichi Mizuta
Journal:  Pediatr Surg Int       Date:  2016-01-19       Impact factor: 1.827

9.  Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment.

Authors:  Pedro Melgar-Lesmes; Mercedes Balcells; Elazer R Edelman
Journal:  Gut       Date:  2016-02-05       Impact factor: 23.059

10.  Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.

Authors:  Hillary J Braun; Jennifer L Dodge; Garrett R Roll; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.